NewsRoom Articles - Page 118 of 229

TuesdayAug 16, 2022 2:32 pm

Research to Examine Potential Link Between Concussions, Long COVID

The first case of COVID-19 was reported in Wuhan, China, in late 2019. In the following months, countries around the world shut down their borders as the virus infected millions of people. Although the virus had a high survival rate of more than 90% in the United States, thousands of patients across the country began reporting coronavirus symptoms that lasted more than two months. Christened long COVID, this condition left patients suffering from symptoms such as cognitive dysfunction, shortness of breath, headache, chest pain and fatigue for up to three months after they contracted COVID-19. According to a report from…

TuesdayAug 16, 2022 10:30 am

QSAM Biosciences Inc. (QSAM) Awarded Patent for Potential Breakthrough Bone Cancer Treatment

This is the third U.S. patent granted to QSAM, further strengthening its IP portfolio, which consists of 14 patents among three patent families. “CycloSam has potential to be a breakthrough therapy for both primary and secondary forms of bone cancer,” says QSAM CEO. Patent covers formulation and preparation of CycloSam in the U.S. QSAM Biosciences (OTCQB: QSAM) has been awarded a key patent for its exclusive radiopharmaceutical drug candidate, CycloSam(R). Granted by the U.S. Patent & Trademark Office, the patent “protects how CycloSam(R) is formulated and prepared, namely by using a nonradioactive kit that can be delivered and stored local to…

MondayAug 15, 2022 12:47 pm

Senate Review Reveals Screening Mistakes Caused Organ Transplant Failures, Illnesses, Deaths

There have been more than 25,000 organ transplants per year in the United States since the mid-2000s. On average, around 95 organ transplants are carried out in the country per day, with someone being added to the national organ transplant waiting list every nine minutes. Kidney transplants tend to have the highest post-transplant survival rate followed by liver, heart and lung transplants. A recent report from the Senate Finance Committee has revealed a disturbing fact: a lack of oversight in the organization charged with supervising organ testing and transplants in the country has led to dozens of cases of illness…

FridayAug 12, 2022 1:41 pm

Researchers Want to Manage Cancer By Keeping Malignant Cells Restricted in Place

Cancer is one of the deadliest diseases on the planet. It affects millions of people across the world, takes more than 10 million lives every year, and still doesn’t have a cure. Most cancer-management therapies involve treatments such as chemotherapy, surgery, radiation therapy and immunotherapy that are meant to remove the cancer cells as much as possible. However, these treatments aren’t always effective, and many patients have gotten cancer again years after the initial cancer was treated. Always on the lookout for novel therapies that can manage and potentially cure cancer, researchers are now exploring how they can manage and…

ThursdayAug 11, 2022 12:21 pm

Study Finds Smells Experienced in Nature Boost Mental Health

Have you ever felt rejuvenated, more alert and in a better mood after stepping out for some fresh air? Breathing in pure clean air, especially when surrounded by nature, can have significant mental and physical benefits. Fresh air cleanses the lungs, strengthens the immune system, increases energy levels, sharpens the mind and individuals happier. New research from the University of Kent’s Durrell Institute of Conservation and Ecology (DICE) has confirmed that smells experienced in nature, such as smelling the rain on earth, can have a positive impact on mental health. Scents like the smell of wet grass on a damp…

ThursdayAug 11, 2022 9:30 am

Odyssey Health, Inc. (ODYY) Redesigns Website, Corporate Presentation, to Update Information on Medical Products, Including Concussion Therapy

Odyssey Health Inc. is a medical product developer advancing treatments for conditions ranging from choking to neurodegenerative maladies The company’s flagship candidate is a drug-device combination for treating mild brain injuries (“MTBIs”) known as PRV-002, which is currently being used in clinical testing with human volunteers Odyssey Health recently announced a redesign of its website and an update of its corporate presentation to better communicate its efforts and allow interested investors to access information regarding the company The website redesign follows on the company’s name change earlier this year to similarly improve the expression of its brand identity Medical technology…

WednesdayAug 10, 2022 2:10 pm

Brain Fingerprinting Adolescents Could Predict Future Mental-Health Issues

New research has demonstrated how the uniqueness of the brain of an adolescent may forecast mental-health outcomes. For this study, researchers focused on the adolescent brain, as changes during this period are dynamic and rapid and help form every individual’s uniqueness. Additionally, most mental-health conditions show up during this period, with more than one-half occurring by the time a child is 14 and about three-quarters of mental-health conditions occurring by the time an individual is 25 years of age. The researchers hypothesize that observing and tracking changes in the brain as they occur may make it easier to tackle emerging…

TuesdayAug 09, 2022 1:36 pm

Research Shows Access to Health Insurance Invaluable in Early Cancer Diagnosis

Cancer is the second most common cause of death in the United States, affecting nearly two million people yearly and taking more than one-half a million lives every year. Almost one-half of the people who suffer from cancer are diagnosed with the deadly condition late. More often than not, late-stage diagnoses significantly limit the effectiveness of treatment and reduce chances of survival. Research by the UK government’s director of cancer services shows that up to 10,000 people die every year due to late-stage cancer diagnoses According to a study published in the “Cancer” journal, pediatric patients from racial and ethnic…

MondayAug 08, 2022 2:01 pm

Researchers Leverage Apps in Treatment of TBI

A 1999 report to Congress stated that traumatic brain injuries (TBIs) are the top cause of disability and death in children and young adults in the United States. Two decades later, an estimated 2.8 million Americans sustain TBIs every year resulting in 280,000 hospitalizations and 50,000 fatalities. Depending on the region of the brain that received trauma, some patients have to deal with long-term effects, including speech difficulties, trouble with logic and understanding others, and apraxia. The cognitive deficiencies caused by TBIs can result in reduced brain activity and significantly impact the patient’s way of life. Although it is virtually…

FridayAug 05, 2022 10:15 am

Combining Immunotherapy with Anti-Rejection Drugs Can Treat Cancer, Prevent Kidney Transplant Rejection

Most kidney transplant patients usually stop taking their immunosuppressive drugs before starting cancer immunotherapy treatment to diminish the chances of their immune systems attacking the transplanted organs. However, a new study has found that combining standard antirejection medication and immune checkpoint inhibitors may benefit kidney transplant patients who suffer from terminal cancer. Immune checkpoint inhibitors are drugs designed to block checkpoints, which are proteins that prevent immune responses in the body from being too strong. Checkpoints also prevent T-cells from eliminating cancer cells. Blocking these checkpoints allows T-cells to eradicate cancer cells more effectively. The study’s objective was to look…